Clinical Trial

A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China

Study acronym: SOAR-HCM
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the effectiveness of mavacamten treatment in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in real-world clinical practice
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2026-01-14; most recent amendment 2026-06-17.
Status change: Not Yet Recruiting → Recruiting 2026-01-28
Trial Details
NCT Number NCT07361289
Lead Sponsor Bristol-Myers Squibb
Conditions Hypertrophic Cardiomyopathy
Enrollment 500 participants
Start Date 2026-01-15
Primary Completion 2028-08-22 (estimated)
Study Completion 2028-08-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-18